Overview
Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis
Status:
Unknown status
Unknown status
Trial end date:
2018-06-20
2018-06-20
Target enrollment:
0
0
Participant gender:
All
All
Summary
This prospective randomised controlled single blind trial comparing the relapse rate in 6 months for 20 mg versus 40 mg intraarticular triamcinolone hexacetonide (Lederspan®) for knee synovitis in patients with rheumatoid arthritis (RA) and psoriatic artritis (PsoA) is performed to find the optimal dose to use.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Uppsala UniversityTreatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria: synovitis of the knee, rheumatoid arthritis or psoriatic arthrthritis,written informed consent
-
Exclusion Criteria:
- inability to understand study information, function class 4 according to Steinbrocker,
planning knee surgery, , joint infection, intraarticular glucocorticoid injection in
this joint the past 3 months, oral glucocortoid treatment corresponding to >10 mg
prednisolone